&w=3840&q=100)
Srinivas Mukkamala: First Indian-origin person to head American Medical Association
During his decades working in organised medicine, Mukkamala has been a fierce advocate for patients. His cancer battle reaffirmed the purpose of his position–to use his platform and lived experience to advocate for a better, more equitable US health system read more
Srinivas Mukkamala was elected President of the American Medical Association, the first person of Indian origin to lead the organisation in its 178-year history.
'To call this moment humbling doesn't capture it,' said Bobby Mukkamala, MD, an otolaryngologist and the AMA's newly inaugurated 180th President. 'It's moving. It's awe-inspiring,' he said.
For many in attendance at the AMA presidential inauguration in Chicago, that inspiration was reciprocal. Last November, a magnetic resonance imaging (MRI) exam revealed an 8-cm temporal lobe tumour on the left side of Mukkamala's brain. Three weeks after the startling discovery, the 53-year-old father of two underwent surgery, as per a statement by AMA.
STORY CONTINUES BELOW THIS AD
The removal of 90 per cent of the tumor was a best-case scenario for Mukkamala. During his decades working in organised medicine, Mukkamala has been a fierce advocate for patients. His cancer battle reaffirmed the purpose of his position–to use his platform and lived experience to advocate for a better, more equitable US health system.
Mukkamala went on to highlight that he, without question, benefited from the best possible treatment. But for many patients, the process of getting care comes with far more troubling questions than reassuring answers: whether insurance will cover a procedure, how much a medication costs, or how long they will wait to see a specialist for something as serious as a lump in their neck, as per the statement.
'Our health system needs the input of many skilled physicians–physician leaders across every state and specialty–who are working together with incredible purpose and urgency,' he said. 'It needs the AMA more than ever, with leaders in our profession speaking with one firm and commanding voice.'
AMA House of Delegates' meeting ran from June 6- June 11, as per the statement.
The AMA has adopted a new policy aimed at promoting public awareness and education about the differences between unhealthful, ultraprocessed foods and healthful foods, as well as the benefits of minimally processed and unprocessed foods. As part of this effort, the policy encourages the integration of nutrition education into all levels of medical education to empower physicians to best counsel patients on reducing unhealthful consumption of ultraprocessed foods.
STORY CONTINUES BELOW THIS AD
(Except for the headline, this story has not been edited by Firstpost staff.)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Gazette
33 minutes ago
- India Gazette
"Felt like an earthquake," Ahmedabad resident relives AI-171 crash experience
Ahmedabad (Gujarat) [India], June 13 (ANI): A resident living in a housing colony near the AI-171 crash site in Ahmedabad, Gujarat, recounted the moment, saying the impact felt like an earthquake. He added that they rushed to the scene immediately after the crash. 'When the crash happened, it felt like an earthquake. Immediately, we rushed to the site. 'After hearing the loud sound from the crash, the public gathered nearby,' he told ANI while recounting the moments of the crash. Hariom Gandhi from the NDRF, who arrived at the AI-171 plane crash site, stated that six teams have been deployed and are actively carrying out operations on the ground. 'Our six teams are working on the ground. We cannot give any numbers until the site is completely cleared,' he said. The Indian Medical Association (IMA ) Gujarat said that its Gujarat unit is working in close collaboration with CM of Gujarat Bhupendra Patel, Ministers Rushikesh Patel & Harsh Sanghavi, Health Secretary Dhananjay Dwivedi, senior IAS officers, government stakeholders, and Civil Hospital authorities. 'In a swift response to the tragic Ahmedabad Flight crash incident, IMA Gujarat is providing full on-ground support at the incident site & Civil Hospital, Ahmedabad. The IMA Gujarat team is working in close collaboration with CM of Gujarat Bhupendra Patel, Ministers Rushikesh Patel & Harsh Sanghavi, Health Secretary Dhananjay Dwivedi, senior IAS officers, government stakeholders, and Civil Hospital authorities as per their direct guidance to deliver the required medical aid & doctors' expertise,' IMA said in a statement. A total of 241 people onboard the Boeing 787-8, Air India flight 171, including 12 crew members, have died in the deadly Ahmedabad plane crash, Air India confirmed post-midnight on Friday. The flight, which was operating from Ahmedabad to London Gatwick on June 12, 2025, carried 169 Indian nationals, 53 British nationals, seven Portuguese nationals, and one Canadian national. The passenger plane crashed near Sardar Vallabhbhai Patel International Airport in Gujarat's Ahmedabad into a resident doctors' hostel building shortly after take-off. Miraculously, one person has survived the deadly crash, the airline authorities said, adding that the survivor was a British national of Indian origin. The aircraft was piloted by Captain Sumeet Sabharwal, a Line Training Captain with 8,200 hours of flying experience, assisted by First Officer Clive Kundar, who had logged 1,100 flying hours. According to Air Traffic Control (ATC), the aircraft departed from Ahmedabad at 1339 IST (0809 UTC) from runway 23. It made a Mayday call to ATC, but thereafter, the aircraft did not respond to the calls made by ATC. Immediately after departing from Runway 23, the aircraft fell on the ground outside the airport perimeter. An official stated that heavy black smoke was emanating from the accident site. The Tata Group has announced a compensation of Rs 1 crore for the families of each person who lost their lives in the crash. (ANI)
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Narayana, Max Healthcare shares gain up to 5%, hit new highs in weak market
Shares of hospitals and healthcare services providers were in demand, and rallied up to 5 per cent on the BSE in Friday's intra-day trade in an otherwise weak market on the back of a healthy outlook. Shares of Narayana Hrudayalaya hit a new high of ₹1,906.15, surging 5 per cent on the BSE in intra-day trade. The stock surpassed its previous high of ₹1,872.85 touched on April 21, 2025. The share price of Max Healthcare Institute also hit a new high of ₹1,234.70, gaining 3 per cent in intra-day trade. It surpassed its earlier high of ₹1,227.50 touched on January 8, 2025. Thyrocare Technologies (up 5 per cent at ₹1,028.90) and Krishna Institute of Medical Sciences or KIMS (up 3 per cent at ₹683.05) were up in the range of 3 per cent and 5 per cent. In comparison, the BSE Sensex was down 0.73 per cent at 81,096 at 02:01 PM. Most Indian hospitals have now broken even and started contributing to profits. There is a rising demand for specialized treatments, including oncology and high-end surgical procedures. This trend is contributing to higher ARPOB (Average Revenue per Occupied Bed) and overall revenue growth. According to analysts at Choice Equity Broking, accounting for ~5-7 per cent of revenue, medical tourism is expected to grow at nearly double the overall rate in the mid-term. Factors such as normalization in the geo-political issue, operationalization of a new airport in Noida, affordable treatment costs, world-class facilities, and skilled medical personnel will continue to attract international patients, particularly from Southeast Asia and the Middle East, analysts said. Meanwhile, India's healthcare sector is on the cusp of significant transformation, driven by increased public and private investments, policy initiatives, and demographic shifts. Despite the current challenges, including disparities in healthcare infrastructure and the availability of medical services in the workforce between urban and rural areas, the future looks promising with sustained efforts and strategic investments. As of 2022, India's healthcare spending accounted for 3.3 per cent of the GDP; however, with sustained efforts, it is anticipated to reach 5 per cent by 2030, according to CareEdge Ratings. Looking forward, the rising share of the population aged over 45 years, coupled with income growth, is also expected to catalyse higher demand for quality healthcare services. This demand will likely translate into sustained investments across the entire value chain, from medical education and training to hospital infrastructure and digital healthcare technologies, the rating agency said. As per latest available data from National Health Accounts (NHA), government healthcare spending has increased significantly in recent years. The government health expenditure (GHE) as a percentage of GDP grew from ~1.1 per cent in FY15 to ~1.8 per cent in FY22. Similarly, its share within the general government expenditure (GGE) saw a notable rise, climbing from ~3.9 per cent in FY15 to ~6.1 per cent in FY22. GHE as a percentage of total health expenditure (THE) grew from 40.8 per cent in FY18 to 48.0 per cent in FY22, demonstrating a shift toward government-funded healthcare. These trends highlight the government's growing commitment to strengthening the healthcare sector. Furthermore, per capita government health expenditure rose from ₹ 1,753 in FY18 to ₹ 3,169 in FY22 at a 16 per cent CAGR, indicating increased spending on healthcare services per individual, analysts at Elara Capital said in the Health Insurance sector update.
India Today
an hour ago
- India Today
How viruses can help the fight against antibiotic resistance
Phage therapies are currently used only in compassionate cases, where all antibiotics have failed and the patient's condition is critical. () Phage therapy uses viruses that specifically infect bacteria India currently relies mostly on antibiotics for infections AI helps identify and analyse over 1.3 million viral genomes Antimicrobial resistance isn't just a silent pandemic â€' India bears one of the heaviest burdens globally. While the country continues its search for new antibiotics to combat the crisis, researchers are now turning to naturally-occurring viruses in the environment as a promising tool to attack and kill multi-drug-resistant bacteria. Karthik Anantharaman, a visiting professor at Wadhwani School of Data Science and AI at IIT Madras, is spearheading such a project in the US by studying the nature of viruses in their natural habitat to attack and kill bacteria, a process called phage therapy. "One approach is to create more antibiotics but this only postpones the problem. New antibiotics also can lead to new forms of resistance, creating a never-ending cycle. An alternative and promising solution is phage therapy, which uses viruses called bacteriophages (or simply phages) to kill specific bacteria," Dr. Anantharaman, who is also a professor at the University of Wisconsin-Madison, told FINDING VIRUSES THAT KILL BACTERIA Anantharaman and his team discovered that viruses have yearly cycles and can affect other organisms in the ecosystem. As part of their study, some viruses were found to carry genes they had taken from the organisms they infected, which helped them carry out important biological functions. The research team also put together over 1.3 million viral genomes â€' the largest collection of its kind so far. Lake Mendota in the US has been monitored consistently since the late 1800s (Photo: Center for Limnology, University of Wisconsin–Madison) "In our lab, we are exploring how phages behave over time. We conducted a 20-year study of a single lake, using DNA sequencing and artificial intelligence (AI) to track how phage populations changed. By sequencing environmental DNA and using AI tools, we identified over 1.3 million viral genomes. This allowed us to see how viruses shift month to month, season to season, and year to year, and to predict their future behaviour," Dr. Anantharaman said. While phage therapy might seem like a relatively new concept to Indian populations and even the West who rely heavily on antibiotics, Anantharaman mentioned that the phenomenon of using viruses to kill bacteria has been used in countries like Russia, Poland, Ukraine, and Georgia for decades. VIRUSES AS ENVIRONMENTAL CLEANER "Our goal is twofold: to improve human health and environmental health. Just as phages (virus) can target harmful bacteria in the human body, they can also be used to clean polluted ecosystems," University of Wisconsin-Madison professor said. For example, if a lake turns black or emits a smell like rotten eggs, a sign of hydrogen sulfide produced by bacteria, phages can be used to selectively kill those bacteria and restore the lake's health. Anantharaman lab group at the University of Wisconsin-Madison, US, pictured by Lake Mendota. Despite their promise, phage therapies are currently used only in compassionate cases, where all antibiotics have failed and the patient's condition is critical. HOW DO PHAGES OR VIRUSES WORK AGAINST BACTERIA? One major reason phages haven't entered mainstream treatment is that researchers still don't fully understand how they evolve over time. Consequently, there are no approved phage-based therapeutic products in India, the US, or Europe. But phages hold great promise, especially when used in combination with antibiotics. Here's how it works: when bacteria face antibiotics, they come under stress. Sometimes, this stress causes genetic changes that make them resistant. But in that process, bacteria may also become vulnerable to phages. So, using both antibiotics and phages together creates a powerful, complementary treatment strategy. In some cases, antibiotics work where phages don't and vice versa. Anantharaman lab member Patricia Tran sampling Lake Mendota, US. over frozen ice in the Winter. "One major advantage of phages is their precision. Unlike antibiotics, which kill both harmful and beneficial bacteria, phages target only one specific strain. If a person is infected with Pseudomonas, the phage used will kill only Pseudomonas, sparing the rest of the body's microbiome. That's a game-changer for preserving overall health during treatment," Anantharaman explained. Another surprising fact is that viruses are everywhere - even inside us. There are 10 to 100 times more viral particles in and on our bodies than human cells. These include many harmless phages that silently regulate bacterial populations. Phages are found in lakes, rivers, soil, oceans, and even in our intestines and on our skin. Anantharaman lab member Dinesh Kumar Kuppa Baskaran sampling Lake Mendota in the Summer. "In our lab, we use AI â€' both machine learning and deep learning â€' to rapidly identify phages from environmental samples. This process, which used to take years, now takes just a day. AI allows us to sift through millions of DNA sequences and pinpoint the viruses that can infect specific harmful bacteria," Anantharaman said. BARRIERS PERSIST However, awareness remains a major barrier. The medical community and industry are still focused on antibiotics. There's limited investment in phage therapy, and the necessary research infrastructure hasn't yet been built. For phage therapy to move forward, government support and academic research are essential. "Industry isn't currently interested in developing phage-based treatments â€' it's mostly up to institutions and public funding. But as the threat of antibiotic resistance grows, this is expected to change," Anantharaman opined. Phage therapy isn't just a scientific curiosity. It could be a major pillar of future medicine â€' if we choose to invest in it. Antimicrobial resistance isn't just a silent pandemic â€' India bears one of the heaviest burdens globally. While the country continues its search for new antibiotics to combat the crisis, researchers are now turning to naturally-occurring viruses in the environment as a promising tool to attack and kill multi-drug-resistant bacteria. Karthik Anantharaman, a visiting professor at Wadhwani School of Data Science and AI at IIT Madras, is spearheading such a project in the US by studying the nature of viruses in their natural habitat to attack and kill bacteria, a process called phage therapy. "One approach is to create more antibiotics but this only postpones the problem. New antibiotics also can lead to new forms of resistance, creating a never-ending cycle. An alternative and promising solution is phage therapy, which uses viruses called bacteriophages (or simply phages) to kill specific bacteria," Dr. Anantharaman, who is also a professor at the University of Wisconsin-Madison, told FINDING VIRUSES THAT KILL BACTERIA Anantharaman and his team discovered that viruses have yearly cycles and can affect other organisms in the ecosystem. As part of their study, some viruses were found to carry genes they had taken from the organisms they infected, which helped them carry out important biological functions. The research team also put together over 1.3 million viral genomes â€' the largest collection of its kind so far. Lake Mendota in the US has been monitored consistently since the late 1800s (Photo: Center for Limnology, University of Wisconsin–Madison) "In our lab, we are exploring how phages behave over time. We conducted a 20-year study of a single lake, using DNA sequencing and artificial intelligence (AI) to track how phage populations changed. By sequencing environmental DNA and using AI tools, we identified over 1.3 million viral genomes. This allowed us to see how viruses shift month to month, season to season, and year to year, and to predict their future behaviour," Dr. Anantharaman said. While phage therapy might seem like a relatively new concept to Indian populations and even the West who rely heavily on antibiotics, Anantharaman mentioned that the phenomenon of using viruses to kill bacteria has been used in countries like Russia, Poland, Ukraine, and Georgia for decades. VIRUSES AS ENVIRONMENTAL CLEANER "Our goal is twofold: to improve human health and environmental health. Just as phages (virus) can target harmful bacteria in the human body, they can also be used to clean polluted ecosystems," University of Wisconsin-Madison professor said. For example, if a lake turns black or emits a smell like rotten eggs, a sign of hydrogen sulfide produced by bacteria, phages can be used to selectively kill those bacteria and restore the lake's health. Anantharaman lab group at the University of Wisconsin-Madison, US, pictured by Lake Mendota. Despite their promise, phage therapies are currently used only in compassionate cases, where all antibiotics have failed and the patient's condition is critical. HOW DO PHAGES OR VIRUSES WORK AGAINST BACTERIA? One major reason phages haven't entered mainstream treatment is that researchers still don't fully understand how they evolve over time. Consequently, there are no approved phage-based therapeutic products in India, the US, or Europe. But phages hold great promise, especially when used in combination with antibiotics. Here's how it works: when bacteria face antibiotics, they come under stress. Sometimes, this stress causes genetic changes that make them resistant. But in that process, bacteria may also become vulnerable to phages. So, using both antibiotics and phages together creates a powerful, complementary treatment strategy. In some cases, antibiotics work where phages don't and vice versa. Anantharaman lab member Patricia Tran sampling Lake Mendota, US. over frozen ice in the Winter. "One major advantage of phages is their precision. Unlike antibiotics, which kill both harmful and beneficial bacteria, phages target only one specific strain. If a person is infected with Pseudomonas, the phage used will kill only Pseudomonas, sparing the rest of the body's microbiome. That's a game-changer for preserving overall health during treatment," Anantharaman explained. Another surprising fact is that viruses are everywhere - even inside us. There are 10 to 100 times more viral particles in and on our bodies than human cells. These include many harmless phages that silently regulate bacterial populations. Phages are found in lakes, rivers, soil, oceans, and even in our intestines and on our skin. Anantharaman lab member Dinesh Kumar Kuppa Baskaran sampling Lake Mendota in the Summer. "In our lab, we use AI â€' both machine learning and deep learning â€' to rapidly identify phages from environmental samples. This process, which used to take years, now takes just a day. AI allows us to sift through millions of DNA sequences and pinpoint the viruses that can infect specific harmful bacteria," Anantharaman said. BARRIERS PERSIST However, awareness remains a major barrier. The medical community and industry are still focused on antibiotics. There's limited investment in phage therapy, and the necessary research infrastructure hasn't yet been built. For phage therapy to move forward, government support and academic research are essential. "Industry isn't currently interested in developing phage-based treatments â€' it's mostly up to institutions and public funding. But as the threat of antibiotic resistance grows, this is expected to change," Anantharaman opined. Phage therapy isn't just a scientific curiosity. It could be a major pillar of future medicine â€' if we choose to invest in it. Join our WhatsApp Channel
